# Severe Lower Urinary Tract Dysfunction in Otherwise Healthy Children: A Three-Case Series and Narrative Review

**Authors:** Olivia-Oana Stanciu, Andreea Moga, Laura Balanescu, Mircea Andriescu, Ruxandra Caragata, Radu Balanescu

PMC · DOI: 10.3390/pediatric18010020 · Pediatric Reports · 2026-02-03

## TL;DR

This paper presents three cases of severe bladder dysfunction in healthy children and emphasizes the importance of early diagnosis and conservative treatment to prevent complications.

## Contribution

The study highlights the functional heterogeneity and reversibility of severe non-neurogenic lower urinary tract dysfunction in children.

## Key findings

- Urodynamic evaluation revealed distinct functional phenotypes in three children with no neurological or structural abnormalities.
- Multimodal conservative management improved bladder function and reduced infections in most patients during follow-up.
- Early functional diagnosis is critical to avoid misdiagnosis and unnecessary interventions.

## Abstract

Background: Severe lower urinary tract dysfunction (LUTD) in neurologically and anatomically normal children is uncommon and frequently underdiagnosed. When severe, functional voiding disorders may closely mimic obstructive or reflux pathology, leading to diagnostic errors, unnecessary invasive procedures, and potential risk to the upper urinary tract. Case presentation: We present three pediatric cases (aged 3–10 years) referred for recurrent febrile urinary tract infections, incontinence, or acute urinary retention in the absence of neurological or structural abnormalities. Urodynamic evaluation identified three distinct severe functional phenotypes: detrusor overactivity with reduced bladder capacity, poor compliance with detrusor–sphincter dyssynergia and secondary high-grade vesicoureteral reflux (Hinman syndrome), and detrusor underactivity with significant post-void residual volumes. All patients demonstrated marked bladder wall remodeling on cystoscopy, including trabeculation and pseudopolypoid mucosal changes. Case discussion: Despite similar clinical severity, the cases illustrated substantial functional heterogeneity and differing risks of upper urinary tract involvement. Urodynamic phenotyping proved central to diagnosis, differentiation from structural disease, and treatment planning. Multimodal conservative management—including urotherapy, pelvic floor biofeedback, targeted pharmacologic therapy, and, when indicated, clean intermittent catheterization or antibiotic prophylaxis—led to resolution of recurrent infections and meaningful improvement in bladder function during medium-term follow-up, although symptom recurrence occurred in one patient after treatment withdrawal. Conclusions: These cases highlight the heterogeneity and potential reversibility of severe functional LUTD in otherwise healthy children. Early functional recognition based on urodynamic assessment is essential to avoid misdiagnosis, prevent unnecessary surgical intervention, and protect renal function. Conservative, function-oriented management remains the cornerstone of effective treatment. The findings are discussed in the context of the existing literature on severe non-neurogenic LUTD and Hinman syndrome.

## Linked entities

- **Diseases:** vesicoureteral reflux (MONDO:0006007), Hinman syndrome (MONDO:0019395)

## Full-text entities

- **Diseases:** detrusor and renal damage (MESH:D007674), spinal or perineal anomalies (MESH:D009437), dry mouth (MESH:D014987), neurogenic lesions (MESH:D020078), constipation (MESH:D003248), LUTD (MESH:D014570), incontinence (MESH:D014549), detrusor underactivity (MESH:D000077295), abnormalities (MESH:D000014), urethral obstruction (MESH:D014524), posterior (MESH:D001041), renal scarring (MESH:D005921), spinal dysraphism (MESH:D016135), urinary retention (MESH:D016055), urethral stricture (MESH:D014525), CIC (MESH:D014202), bacterial colonization (MESH:D015179), hypertension (MESH:D006973), VUR (MESH:D014718), detrusor-sphincter dyssynergia (MESH:D001259), daytime incontinence (MESH:D053207), detrusor hypertrophy (MESH:D006984), infection (MESH:D007239), hydronephrosis (MESH:D006869), detrusor-sphincter discoordination (MESH:D009122), discoordination (MESH:C562757), UTIs (MESH:D014552), neurological disease (MESH:D020271), febrile (MESH:D000071072), lesions (MESH:D009059), spinal abnormalities (MESH:D016472), structural abnormalities (MESH:C566527), renal deterioration (MESH:D058186), scarring (MESH:D002921), diverticula (MESH:D004240), BBD (MESH:D001745), fever (MESH:D005334), renal compromise (MESH:D006030), tethered cord (MESH:D009436), spinal lesions (MESH:D013122), neurological (MESH:D009461), dysuria (MESH:D053159), bladder neck obstruction (MESH:D001748), inflammatory (MESH:D007249), disease (MESH:D004194), neurological lesion (MESH:D019636), injury to (MESH:D014947), reflux (MESH:D005764), Hinman Syndrome (MESH:D013577), CAP (MESH:D004761), blurred vision (MESH:D014786), sacral agenesis (MESH:C537221), pain (MESH:D010146), neurogenic (MESH:D001750), valves (MESH:D006349), detrusor (MESH:D053201), renal failure (MESH:D051437), behavioral dysfunction (MESH:D001523), myelomeningocele (MESH:D008591), bacteriuria (MESH:D001437)
- **Chemicals:** ampicillin (MESH:D000667), creatinine (MESH:D003404), Omnic-Tocas (-), Nitrofurantoin (MESH:D009582), cephalosporins (MESH:D002511), amines (MESH:D000588), oxybutynin (MESH:C005419), H2O (MESH:D014867), DMSA (MESH:D004113), Tamsulosin (MESH:D000077409), Trospium Chloride (MESH:C003330)
- **Species:** Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562], Klebsiella pneumoniae (species) [taxon 573]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921987/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12921987/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921987/full.md

---
Source: https://tomesphere.com/paper/PMC12921987